Investigations focusing on the interplay between immune cell populations and the OS microenvironment have elucidated that cancer progression is most expedited when anti-tumor immune cells, including DCs, helper T cells, cytotoxic cells and IFN-γ, exhibit a decline in abundance, while regulatory T cells (Treg) undergo an increase [34]. The gene discussed is IFNG; the disease is cancer.